Chris Miller, Ph.D.

Co-Founder, NOWONDER, Inc.

Chris Miller, Ph.D., talks with Casey Miller about his start as a respiratory therapist, building the first nitric oxide delivery devices, and the day he measured nitric oxide in his own nose.Recorded in 2020 · 6 min

Chris Miller, Ph.D., is an internationally recognized scientist, biotechnology entrepreneur, and pioneer in the research and development of nitric oxide technologies. With more than three decades of experience advancing nitric oxide science, clinical research, and commercialization, Chris has dedicated his career to translating innovative science into meaningful medical and consumer health applications.

He earned his Ph.D. in Experimental Medicine from the University of British Columbia, specializing in respiratory and infectious diseases, with doctoral research focused on the properties of exogenous nitric oxide. His pioneering work helped advance the understanding and application of gaseous nitric oxide as a potential technology for addressing infectious diseases, including some of the earliest human applications in infected wounds and drug-resistant respiratory disease.

Throughout his scientific career, Chris has authored more than 40 peer-reviewed publications, holds multiple patents and patent applications in nitric oxide technologies, and has been invited to lecture at national and international professional forums. He has also established and led research programs, trained the next generation of scientists, and secured more than $12 million in research grants.

Beyond his scientific contributions, Chris brings substantial entrepreneurial and commercial experience to the biotechnology industry. He has co-founded multiple biotechnology companies, served in senior executive and Chief Executive Officer roles, raised more than $20 million in capital, and negotiated multimillion-dollar licensing and development agreements with major international pharmaceutical companies. His experience spans scientific discovery, intellectual property development, clinical trial design, regulatory strategy, product development, and commercialization.

Chris has also played an important role in advancing nitric oxide delivery technologies, contributing to the design and regulatory approval of two of the three human nitric oxide delivery devices identified in his professional record. His experience working with the U.S. FDA, Health Canada, and international regulatory frameworks gives him a distinctive understanding of the path from scientific innovation to commercial application.

What distinguishes Chris is his rare combination of deep scientific expertise, practical clinical experience, and entrepreneurial vision. He understands not only the science behind emerging technologies, but also what it takes to develop, validate, regulate, and bring those technologies to market.

Today, Chris continues to champion the potential of nitric oxide as a versatile platform for innovation across healthcare and consumer applications, driven by the belief that its possibilities extend well beyond its established uses.

Chris Miller, Ph.D.